Retour
30
Fourchette du Jour
15,30 €
15,30 €
Fourchette 52 Semaines
11,15 €
15,30 €
Volume
893
Moyenne 50J / 200J
15,30 €
/
15,30 €
Clôture Précédente
15,30 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 23,6 | 0,4 |
| P/B | 0,8 | 2,9 |
| ROE % | 3,4 | 3,9 |
| Net Margin % | 2,7 | 3,8 |
| Rev Growth 5Y % | 4,1 | 10,0 |
| D/E | 0,1 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2029 |
1,05 €
1,05 € – 1,05 €
|
2,04B | 1 |
| FY2028 |
0,94 €
0,94 € – 0,94 €
|
1,94B | 1 |
| FY2027 |
0,84 €
0,84 € – 0,84 €
|
1,85B | 1 |
No quarterly estimates available
Dividend History
Yield
0,00%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Revenue grew 4,07% annually over 5 years — modest growth
ROE of 3,40% is below average
Debt/Equity of 0,12 — conservative balance sheet
Generating 57,20M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 12,09%
Cash machine — converts 131,95% of earnings into free cash flow
Croissance
Revenue Growth (5Y)
4,07%
Revenue (1Y)-8,02%
Earnings (1Y)11,98%
FCF Growth (3Y)421,90%
Qualité
Return on Equity
3,40%
ROIC2,50%
Net Margin2,72%
Op. Margin3,02%
Sécurité
Debt / Equity
0,12
Current Ratio2,23
Interest Coverage14,16
Valorisation
P/E Ratio
23,62
Forward P/EN/A
P/B Ratio0,79
EV/EBITDA18,57
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -8,02% | Revenue Growth (3Y) | 5,04% |
| Earnings Growth (1Y) | 11,98% | Earnings Growth (3Y) | 31,31% |
| Revenue Growth (5Y) | 4,07% | Earnings Growth (5Y) | 133,79% |
| Profitability | |||
| Revenue (TTM) | 1,60B | Net Income (TTM) | 43,35M |
| ROE | 3,40% | ROA | 2,34% |
| Gross Margin | 10,77% | Operating Margin | 3,02% |
| Net Margin | 2,72% | Free Cash Flow (TTM) | 57,20M |
| ROIC | 2,50% | FCF Growth (3Y) | 421,90% |
| Safety | |||
| Debt / Equity | 0,12 | Current Ratio | 2,23 |
| Interest Coverage | 14,16 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 23,62 | Forward P/E | N/A |
| P/B Ratio | 0,79 | P/S Ratio | 0,64 |
| PEG Ratio | 1,22 | Forward PEG | N/A |
| EV/EBITDA | 18,57 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 5,59% | ||
| Market Cap | 1,02B | Enterprise Value | 893,89M |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 1,60B | 1,73B | 1,45B | 1,59B | 1,36B |
| Net Income | 43,35M | 38,71M | 25,14M | 28,30M | 1,45M |
| EPS (Diluted) | 0,67 | 0,58 | 0,38 | 0,42 | 0,02 |
| Gross Profit | 171,82M | 202,88M | 999,52M | 182,63M | 937,72M |
| Operating Income | 48,15M | 40,40M | 36,11M | 30,52M | 10,60M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 1,86B | 1,77B | 1,70B | 1,67B | 1,63B |
| Total Liabilities | 530,51M | 490,30M | 453,51M | 440,82M | 439,45M |
| Shareholders' Equity | 1,30B | 1,25B | 1,22B | 1,20B | 1,17B |
| Total Debt | 149,60M | 149,90M | 158,20M | 159,76M | 160,60M |
| Cash & Equivalents | 279,86M | 206,04M | 77,33M | 126,32M | 90,96M |
| Current Assets | 904,11M | 789,21M | 688,61M | 611,08M | 566,43M |
| Current Liabilities | 404,85M | 335,47M | 291,08M | 273,31M | 273,38M |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#638 of 827
Activité Récente
Entré
Deep Value Investing (Seth Klarman)
Mar 24, 2026